Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 11:39 | 11 Aug | 1040.40 |
2.20 (0.21%) |
OPEN
1044.90 |
HIGH
1048.45 |
LOW
1036.20 |
| NSE 11:29 | 11 Aug | 1040.95 |
2.60 (0.25%) |
OPEN
1040.50 |
HIGH
1049.00 |
LOW
1036.70 |
| OPEN | 1044.90 |
| PREVIOUS CLOSE | 1038.20 |
| VOLUME | 11079 |
| 52-Week high | 1083.15 |
| 52-Week low | 850.00 |
| P/E | 28.70 |
| Mkt Cap.(Rs cr) | 83,960 |
| Buy Price | 1040.40 |
| Buy Qty | 26.00 |
| Sell Price | 1041.35 |
| Sell Qty | 138.00 |
Cipla Ltd. (CIPLA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 919.50 | 0.15 | 0.02 | 15585.98 |
| Dr Reddy's Labs | 4262.00 | 19.60 | 0.46 | 14405.20 |
| Cipla | 1040.40 | 2.20 | 0.21 | 13091.79 |
| Lupin | 679.85 | 10.15 | 1.52 | 11771.67 |
| Aurobindo Pharma | 571.25 | 7.00 | 1.24 | 11287.14 |
| Divi's Lab. | 3925.65 | -20.00 | -0.51 | 8879.82 |
| Alkem Lab | 2982.20 | 24.65 | 0.83 | 8829.81 |
| Zydus Lifesci. | 372.25 | 7.60 | 2.08 | 7981.90 |
| Glenmark Pharma. | 371.95 | -3.75 | -1.00 | 7567.93 |
| Torrent Pharma. | 1533.30 | -7.60 | -0.49 | 6742.32 |
| Apollo Hospitals | 4454.45 | -64.60 | -1.43 | 6098.30 |
| Ipca Labs. | 1011.55 | 19.70 | 1.99 | 5399.36 |
| Alembic Pharma | 650.80 | -1.55 | -0.24 | 5051.44 |
| Abbott India | 19399.95 | -208.25 | -1.06 | 4919.27 |
| Laurus Labs | 565.10 | 6.40 | 1.15 | 4707.04 |
| Gland Pharma | 2332.20 | 24.90 | 1.08 | 4400.71 |
| Granules India | 301.85 | 0.20 | 0.07 | 3238.44 |
| Glaxosmi. Pharma | 1446.15 | 1.15 | 0.08 | 3217.51 |
| Ajanta Pharma | 1275.35 | 2.75 | 0.22 | 3140.64 |
| Sanofi India | 6460.00 | 44.95 | 0.70 | 2956.60 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
